28.4 C
Vientiane
Sunday, June 22, 2025
spot_img
Home Blog Page 973

‘I’M GOING TO SCOTLAND’: HARRISON FORD BECOMES THE FACE OF GLENMORANGIE SINGLE MALT WHISKY

‘Unconventional’ campaign sees Hollywood icon star alongside distillery team 

EDINBURGH, Scotland, Jan. 28, 2025 /PRNewswire/ — Glenmorangie Highland single malt Scotch whisky has today revealed a new global campaign starring cinematic icon, Harrison Ford. Legendary for his countless iconic movie roles, the Hollywood actor brings his trademark wry humour to the fore in a series of episodic films directed by actor and film-maker Joel Edgerton.

Once Upon a Time in Scotland takes us behind-the-scenes as Harrison Ford journeys to Glenmorangie’s Highland home, to discover the skill and craftmanship that goes into making each bottle of its complex and elegant whisky. It sees the actor enjoy the authentic Scottish experience — from getting to grips with the nuances of Scottish pronunciation and kilt etiquette, to bonding with locals over a dram of single malt — all shot in an unconventional, deliberately ‘off-script’ style.

Filmed in the picturesque north-east Highlands of Scotland, the campaign captures the natural beauty of the local area: from the historic distillery in Tain where Glenmorangie has been created for over 180 years, to the storied 19th century Ardross Castle, and the dramatic landscapes surrounding Loch Glass. Appearing alongside Ford are the real Glenmorangie distillery team — who embraced their first experience of acting under the guidance of a global cinematic legend — while the brand’s flagship whiskies, Glenmorangie Original 12 Years Old and Glenmorangie Infinita 18 Years Old also take on a starring role.

Edgerton’s 12 episodes and hero film are complemented by still images shot by acclaimed fashion photographer Lachlan Bailey. They feature Ford as he’s never been seen before: donning a stylish Scottish kilt designed by streetwear brand Palace.

Caspar MacRae, President & CEO of The Glenmorangie Company, said:

Harrison Ford is the real deal: a true global icon, and a genuine whisky lover. It was a dream come true to collaborate on this campaign, and welcome him to our home in the Highlands to discover more about Glenmorangie. He is someone who has honed his craft over decades, which gives him a real appreciation for the dedication and skill of our distillery team. Like us, he’s not afraid to laugh at himself — and I think Joel has perfectly captured his authentic warmth, alongside his roguish sense of humour.

“We hope whisky lovers around the world will enjoy exploring the episodes, and learning more about the real people and places behind our whiskies, through Harrison’s eyes.”

Harrison Ford, star of Once Upon a Time in Scotland, said:

“I loved working with the team at the Distillery — they were all great. The whole process of filming was full of unanticipated joys: little unexpected moments. It’s a tribute to Glenmorangie’s sensibilities that they let us be less than totally serious. I think what Joel has produced has a certain charm to it, because it’s unpretentious and just amusing.”

Joel Edgerton, Director, Once Upon a Time in Scotland, said:

“I’ve spent my whole life watching commercials that follow an expected format and so I really like it when things are a little disruptive, fun, and irreverent. It was nice that we got a chance within the very traditional industry of whisky to get behind the scenes, to subvert the seriousness that often goes into an advertising campaign and have fun with that. I hope that people get to see the short film and the full-length episodes — and enjoy them and share them around.”

Once Upon a Time in Scotland will roll out globally from 28 January 2025 spanning online video, connected TV, out-of-home formats, experiential, PR and social media. Six full-length episodes and an array of behind-the-scenes content will initially be available to view on glenmorangie.com, with the rest released throughout 2025.

Instagram: @glenmorangie #glenmorangie
glenmorangie.com

ABOUT GLENMORANGIE

Glenmorangie’s whisky makers use endless imagination and five key ingredients — wood, water, barley, yeast and time — to dream up delicious single malt whiskies. They’ve been honing their craft for more than 180 years. They create a delicate and fruity spirit in Scotland’s tallest stills to allow for more taste and aroma. Led by Director of Whisky Creation Dr Bill Lumsden, this pioneering crew are on a mission to bring new flavours and possibilities to the world of single malt.

ABOUT ONCE UPON A TIME IN SCOTLAND

With Once Upon a Time in Scotland, Glenmorangie focuses on the significance of its home, its craftsmanship and the people that make its award-winning whiskies, offering a playful yet authentic view of the place that fuels Glenmorangie’s endless imagination.

Harrison Ford becomes the face of Glenmorangie Single Malt Whisky
Harrison Ford becomes the face of Glenmorangie Single Malt Whisky

 

 

6D Technologies Wins Landmark Deal to Revolutionize Payments for MMG Guyana with Aureus Platform

BANGALORE, India, Jan. 28, 2025 /PRNewswire/ — 6D Technologies is proud to announce its partnership with Mobile Money Guyana (MMG) to transform the payment ecosystem in Guyana using the cutting-edge Aureus platform. This collaboration marks a significant milestone in their mission to deliver innovative solutions that redefine customer engagement and financial services.

Aureus is designed to revolutionize how customers interact with mobile money by integrating loyalty and gamification at its core. Through this partnership, MMG will offer its users a dynamic and engaging experience that goes beyond transactions. With features such as cashback rewards, point-based incentives, and exclusive offers, every transaction becomes an opportunity for customers to reap tangible benefits.

“With Aureus, we will redefine the mobile money experience for our customers,” said Mark Singh, CEO of MMG. “By combining loyalty and gamification, we will not just provide financial services—we will create meaningful interactions that reward trust, build engagement, and deliver exceptional value.”

Aureus also introduces gamification elements like challenges, milestones, and leaderboards, making the payment journey more interactive and rewarding. These features are aimed at boosting user engagement, fostering customer loyalty, and driving increased adoption of mobile money services across Guyana.

“We are thrilled to collaborate with MMG to revolutionize mobile payments in Guyana,” said Abhilash Sadanandan, CEO and Co-Founder of 6D Technologies. “At 6D Technologies, our mission is to empower businesses with solutions that combine cutting-edge technology and customer-centric innovation. Aureus is a testament to this vision, and we are excited to see how it will transform customer experiences and foster financial inclusion in Guyana.”

The deal underscores 6D Technologies’ commitment to empowering telecom operators and financial service providers with transformative digital solutions. By leveraging Aureus, MMG is set to achieve operational excellence, enhance customer satisfaction, and strengthen its leadership in the mobile financial services space.

About MMG Guyana

Mobile Money Guyana (MMG) is Guyana’s leading mobile financial service provider, offering secure, convenient, and innovative solutions for individuals and businesses. Committed to fostering financial inclusion, MMG delivers accessible services that empower communities and drive economic growth.

About 6D Technologies

6D Technologies is a leading provider of innovative digital transformation solutions for telecom operators and financial service providers worldwide. With cutting-edge solutions, 6D Technologies empowers businesses to deliver seamless experiences, drive engagement, and achieve operational excellence in an ever-evolving digital ecosystem. For more information, visit https://www.6dtechnologies.com/

 

 

Russell Reynolds Associates Expands APAC Financial Services Team with Appointment of Frazer Wilson as Managing Director

SYDNEY, Jan. 28, 2025 /PRNewswire/ — Global leadership advisory firm Russell Reynolds Associates (RRA) is pleased to announce the appointment of Frazer Wilson as a managing director. Wilson’s appointment highlights RRA’s dedication to enhancing its presence in the financial services sector in Oceania, aiming to expand this vital area of business. Based in Sydney, Wilson has over 20 years of experience advising Boards and C-suite leaders across the financial services sector, including consumer, commercial, and investment banking, wealth management, and financial disruptors.

Russell Reynolds Associates welcomes Frazer Wilson
Russell Reynolds Associates welcomes Frazer Wilson

“James and I are thrilled to welcome Frazer to the firm. His extensive experience and expertise in financial services will be invaluable in helping our global and regional clients enhance their talent strategies,” said Alistair Macrae, Managing Director and Australia Country Manager for Russell Reynolds Associates. “In the current complex business environment, his deep understanding of the sector and proven track record in advising Boards and C-suite leaders will ensure that we continue to deliver exceptional leadership solutions tailored to our clients’ needs.”

Prior to joining Russell Reynolds Associates, Wilson was a partner in another leading global executive search organization. During his tenure there, Wilson worked across Australia, New Zealand, and for five years led the Asia-Pacific and Middle East Financial Services practice based in Singapore. For over 10 years, he led one of the firm’s major financial services client relationships. His track record has encompassed Board, Chief Executive Officers, Chief Financial Officers, Chief Risk Officers, P&L, Digital & Technology, and Human Resources appointments.

Wilson began his executive recruitment career in London in 1995.

Wilson holds a Bachelor of Commerce from the University of Auckland.

About Russell Reynolds Associates

Russell Reynolds Associates is a global leadership advisory firm. Our 500+ consultants in 47 offices work with public, private, and nonprofit organizations across all industries and regions. We help our clients build teams of transformational leaders who can meet today’s challenges and anticipate the digital, economic, sustainability, and political trends that are reshaping the global business environment. From helping boards with their structure, culture, and effectiveness to identifying, assessing and defining the best leadership for organizations, our teams bring their decades of expertise to help clients address their most complex leadership issues. We exist to improve the way the world is led. www.russellreynolds.com

Telix Completes Acquisition of RLS (USA) Inc.

MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of RLS (USA) Inc. (RLS; RLS Radiopharmacies), America’s only Joint Commission-accredited radiopharmacy network distributing PET[1], SPECT[2] and therapeutic radiopharmaceuticals. 

The acquisition immediately enhances Telix’s presence in the United States (U.S.), with a network of over 30 radiopharmacies[3] dispensing radiopharmaceuticals manufactured by Telix and other companies, while bringing a team of highly-skilled and multi-disciplinary radiopharmaceutical professionals into the Company.  

The acquisition is part of Telix’s strategy to establish an integrated radiopharmaceutical ecosystem, enhancing its ability to deliver novel therapeutic and diagnostic radiopharmaceuticals to patients. The RLS footprint of over 100,000 square ft of appropriately licensed expansion space provides the opportunity to build a next-generation radiometal production network to benefit Telix, select commercial partners, and patients. 

RLS will continue to operate under the same name and as a standalone business within Telix Manufacturing Solutions (TMS), which includes other key Telix brands with multi-vendor and third-party relationships such as ARTMS, IsoTherapeutics and Optimal Tracers.

The addition of RLS’s operations will significantly strengthen Telix’s commercial infrastructure and distribution capabilities in its largest market, including the capacity to undertake in-house cyclotron manufacturing powered by Telix’s ARTMS QUANTM Irradiation System™ (QIS™) cyclotron technology, enabling standardized, high-efficiency and cost-effective production of radiometals.

Dr. Christian Behrenbruch, Telix Managing Director and Group Chief Executive Officer, said, “We are pleased to officially welcome the RLS team to Telix. The completion of this acquisition marks a milestone in our journey to become the leader in radiopharmaceuticals, as the RLS network significantly boosts our existing in-house and partner capabilities. With RLS’s distribution and operational expertise, Telix is strongly positioned to bring our growing portfolio of innovative products to more patients across the U.S.”

Stephen Belcher, RLS Chief Executive Officer, added, “The RLS team is delighted to be joining Telix, as we combine our 40-year history in radiopharmaceuticals with Telix’s growing investment in its North American footprint. Together we can accelerate the availability of transformative radiopharmaceuticals and build on our respective commitments to innovative patient care. We are excited to be part of the Telix story going forward.”

Acquisition Details

Under the previously disclosed terms of the transaction[4], Telix has acquired 100% ownership of RLS (USA) Inc. The purchase price comprised of upfront cash consideration of US$230 million before adjustments for cash and cash equivalents (net of restricted cash); debt and debt equivalents; transaction expenses; and working capital, and deferred cash consideration up to a maximum of US$20 million, contingent on achievement of certain milestones related to demonstration of accretive financial and operational performance during the four-quarters following closing. The acquisition and related transaction costs were funded from existing cash reserves.

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. ARTMS, IsoTherapeutics, Lightpoint, Optimal Tracers and RLS are Telix Group companies. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).

Telix’s lead prostate imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[5], by the Australian Therapeutic Goods Administration (TGA)[6], and by Health Canada[7]. Telix has received a positive decision on its Marketing Authorization Application (MAA) for Illuccix submitted in Europe[8].

Telix’s osteomyelitis (bone infection) imaging agent, technetium-99m (99mTc) besilesomab, marketed under the brand name Scintimun®, is approved in 32 European countries and Mexico. Telix’s miniaturized surgical gamma probe, SENSEI®, for minimally invasive and robotic-assisted surgery, is approved in the U.S., having been registered with the FDA and has attained a Conformité Européenne (CE) Mark for use in the European Economic Area for the intra-operative detection of sentinel lymph nodes (SLNs). No other Telix product has received a marketing authorization in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and SEC filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedInX and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the anticipated benefits of Telix’s acquisition of RLS; the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Telix Group company, and Telix product names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. Trademark registration status may vary from country to country.

[1] Positron emission tomography.

[2] Single-photon emission computed tomography.

[3] In January 2025, RLS completed the acquisition of Advanced Isotopes of Nevada, a Las Vegas-based radiopharmacy, now operating under Las Vegas Radiopharmacy Inc., a wholly-owned subsidiary of RLS.

[4] Telix ASX disclosure 23 September 2024.

[5] Telix ASX disclosure 20 December 2021.

[6] Telix ASX disclosure 2 November 2021.

[7] Telix ASX disclosure 14 October 2022.

[8] Telix ASX disclosure 17 January 2025.

 

Autozi Internet Technology (Global) Ltd. Announces Fiscal Year 2024 Financial Results and Files Its Annual Report on Form 20-F

BEIJING, Jan. 28, 2025 /PRNewswire/ — Autozi Internet Technology (Global) Ltd. (“Autozi” or the “Company”) (Nasdaq: AZI), one of the leading and fast-growing lifecycle automotive service providers in China, today announced its financial results for the fiscal year ended September 30, 2024. The Company also filed its annual report on Form 20-F for the fiscal year ended September 30, 2024 with the Securities and Exchange Commission (the “SEC”) on January 27, 2025, U.S. Eastern Time. The annual report can be accessed on the SEC’s website at www.sec.gov.

Management Commentary

Dr. Houqi Zhang, Founder, Chairman, and Chief Executive Officer of Autozi, commented. “As we conclude a successful fiscal year 2024, I am proud of Autozi’s continued progress in advancing our supply chain digitalization platform, which is a core driver of our strategic transformation toward a more intelligent and light-asset business model. Leveraging cutting-edge technologies such as artificial intelligence, big data, cloud computing, and the Internet of Things, we have significantly enhanced our end-to-end digital integration, enabling more efficient collaboration and streamlined processes across the entire supply chain. In addition, we completed our initial public offering on the NASDAQ Global Market in August, further expanding our access to capital, heightening our brand visibility, and marking our entrance to the global stage.”

Dr. Zhang continued, “Looking ahead, our focus remains on empowering participants across the entire supply chain ecosystem by creating a direct-to-consumer network for auto service shops and car owners, offering seamless, convenient, and reliable one-stop lifecycle services. We are actively exploring opportunities to expand our multi-business ecosystem, pursuing strategic acquisitions in key verticals to strengthen our leadership in the industry. Meanwhile, we remain focused on maintaining stable profitability through disciplined cost management and operational efficiencies. We are also committed to continuing the optimization of our capital structure, ensuring a stronger financial position to support our long-term strategic objectives and create sustainable value for our shareholders.”

Fiscal Year 2024 Financial Results

Revenues increased by 9.9% to $124.7 million in fiscal year 2024 from $113.5 million in the prior year. The Company’s revenues were recognized in RMB and reported in U.S. dollar, and the depreciation of the RMB against the U.S. dollar during the fiscal year negatively impacted the reported year-over-year growth rate. On a constant currency basis in RMB terms, the Company’s revenues grew by approximately 12.2% year over year. This growth was driven by the Company’s strategic shift towards focusing on its auto parts and auto accessories sales segment, which more than offset declines in other business lines. With a continued emphasis on this high-margin, growth-oriented segments, Autozi remains well-positioned for future expansion and sustained improvement in its margin profiles.

  • Revenues from auto parts and auto accessories sales increased significantly by 86.1% to $68.6 million in fiscal year 2024 from $36.8 million in the prior year as a result of successful market expansion and increased sales volume. The increase reflects the Company’s ongoing efforts to refine its auto parts and accessories portfolio, establish new partnerships with new customers, and strengthen relationships with existing customers.
  • Revenues from new car sales decreased by 24.3% to $55.8 million in fiscal year 2024 from $73.7 million in the prior year. During the fiscal year, the Company made a strategic decision to gradually scale back its focus on new car sales in response to increasing regulatory complexities, intensifying market competition, shrinking market demand, and decreasing margins in this segment. While the new car sales business continues to provide brand influence and market presence, supporting the broader auto parts and auto accessories operations, the Company does not expect significant future investment in this segment. This shift allows Autozi to prioritize its growth in higher-margin areas with stronger long-term potential.
  • Revenues from automotive insurance-related services decreased to $0.4 million in fiscal year 2024 from $3.0 million in the prior year. This decrease was due to industry-wide regulatory changes that introduced new requirements, which led the Company to discontinue its insurance-related services at the end of fiscal year 2023. While automotive insurance may remain a potential component of our broader ecosystem in the future, any re-engagement in this area will be contingent upon identifying suitable strategic partnerships or acquisition opportunities that align with the Company’s long-term growth objectives.

Cost of revenues increased by 9.2% to $123.5 million in fiscal year 2024 from $113.0 million in the prior year. This increase reflects changes in the cost structure across various business segments, which are directly aligned with the revenue performance.

Gross profit was $1.3 million for fiscal year 2024, an increase of $0.8 million from $0.5 million in fiscal year 2023. This represents a gross profit margin of 1.0% for fiscal year 2024, compared to 0.4% in the prior year. This improvement was primarily driven by stronger profitability in the auto parts and auto accessories sales segment, which reflects the Company’s strategic focus on expanding this high-margin business. In fiscal year 2024, revenues from auto parts and auto accessories sales accounted for 55.0% of total revenues, up from 32.5% in fiscal year 2023. Furthermore, increased procurement efforts during the year allowed Autozi to leverage greater bargaining power with upstream suppliers, enhancing profitability in this segment. As a result, the gross profit margin for the auto parts and auto accessories sales segment improved from 1.0% in fiscal year 2023 to 1.8% in fiscal year 2024, underscoring the Company’s successful execution of its strategic initiatives in this area.

Operating expenses decreased by 14.3% to $6.7 million in fiscal year 2024 from $7.8 million in the prior year. This reduction was a direct result of the Company’s ongoing efforts to optimize its cost structure, implement stringent expense control initiatives, and improve operational efficiencies.

  • Sales and marketing expenses increased by 11.4% to $1.3 million in fiscal year 2024 from $1.1 million in the prior year. This increase was primarily attributable to higher market promotion expenses, as the Company strategically invested in business development initiatives to support the rapid growth of its auto parts and auto accessories sales segment. Additionally, the expansion of this segment required maintaining adequate inventory levels, leading to a corresponding rise in warehousing and logistics costs. However, these costs remained in line with revenue growth, underscoring the Company’s disciplined approach to balancing investment and operational efficiency while driving long-term growth in its core business.
  • General and administrative expenses decreased by 19.3% to $4.3 million in fiscal year 2024 from $5.4 million in the prior year. The reduction was primarily driven by a $1.6 million decrease in credit losses, which was a result of the full provision for expected losses related to amounts due from affiliated parties in fiscal year 2023. There was no such provisionin fiscal year 2024. This decrease was partially offset by a $0.6 million increase in staff costs, which were associated with bonuses paid to employees following the Company’s successful Initial Public Offering during the fiscal year, and a $0.1 million increase in additional consulting and professional service fees as a public company.
  • Research and development expenses decreased by 16.4% to $1.1 million in fiscal year 2024 from $1.3 million in the prior year. This decline was mainly the result of a $0.2 million reduction in staff costs, as the Company entered a more mature phase in the development of its service platform. With the initial R&D phase largely completed, the focus has shifted to platform maintenance and optimization, resulting in a stabilization of R&D expenses.

Operating loss narrowed by 25.6% to $5.4 million in fiscal year 2024 from $7.3 million in the prior year. This improvement was a testament to the Company’s continued efforts to optimize its cost structure, implement stringent expense control initiatives, improve operational efficiencies, and increase the revenue contribution from the higher-margin auto parts and auto accessories sales segment.

Net loss was $11.1 million in fiscal year 2024, compared to a net loss of $10.5 million in fiscal year 2023. The increase in the net loss was primarily due to a $1.5 million increase in litigation-related costs, which primarily consisted of accrued penalties for the repurchase of mezzanine equity. While the Company has taken a prudent approach in accounting for this charge, it does not anticipate any actual cash impact. Excluding this charge, the company’s net loss in fiscal year 2024 would have narrowed by 10.5% or $1.0 million to $8.1million.

Full Financial Disclosure

This press release provides a summary of Autozi’s financial results for the fiscal year ended September 30, 2024. It is intended for informational purposes only and does not represent a complete or comprehensive overview of the Company’s financial condition. For a detailed understanding of the Company’s financial performance, results, and related implications, please refer to the Company’s annual report on Form 20-F for fiscal year 2024, filed with the U.S. Securities and Exchange Commission. The Form 20-F contains the Company’s audited financial statements, management’s analysis, and other key disclosures necessary for a full evaluation of its financial position.

Recent Business Developments

Autozi’s continued focus on digital transformation and its industry integration strategy has significantly contributed to the Company’s strong performance and competitive advantage. These efforts have positioned Autozi as a leader in the automotive supply chain ecosystem, paving the way for consolidating this highly-fragmented market and long-term sustainable growth. The Company’s supply chain platform has gained widespread market recognition for its advanced capabilities, including cutting-edge data analytics tools, automated processes, and intelligent inventory management. These innovations have significantly improved the efficiency and responsiveness of the supply chain, enabling the Company to better meet customer demands and streamline operations.

In recent months, Autozi has forged partnerships with 12 provincial distributors, demonstrating its proactive approach to market expansion and its ability to deepen market penetration. These partnerships have broadened the Company’s sales channels and increased market share across diverse regions. Additionally, the establishment of logistics partnerships in eight provinces has strengthened the Company’s distribution network, enhancing its ability to provide faster and more reliable delivery services. The shared supply chain resources strategy has not only reduced operating costs but also improved service quality and customer satisfaction.

As of September 30, 2024, the participants registered in our platforms included 3,410 auto parts and auto accessories manufacturers, 17,964 auto parts and auto accessories dealers and resellers, 79,351 service stores and garages owners. These achievements underscore the Company’s ability to drive operational optimization and resource sharing through digitalization. The resulting expansion of its business scale and improvement in profitability reflect the success of these initiatives. With ongoing enhancements to its digital capabilities and an ever-growing network of partners, Autozi is well-positioned to continue delivering revenue and profit growth in the years to come.

About Autozi Internet Technology (Global) Ltd.

Autozi Internet Technology (Global) Ltd. is a leading, fast-growing provider of lifecycle automotive services in China. Founded in 2010, Autozi offers a comprehensive range of high-quality, affordable, and professional automotive products and services through both online and offline channels across the country. Leveraging its advanced online supply chain cloud platform and SaaS solutions, Autozi has built a dynamic ecosystem that connects key participants across the automotive industry. This interconnected network enables more efficient collaboration and streamlined processes throughout the entire supply chain, positioning Autozi as a key driver of innovation and growth in the automotive services sector.

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. These forward-looking statements speak only as of the date of this announcement, and the Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, as actual results may be impacted by a variety of factors, including without limitation, changes in macroeconomic conditions, industry dynamics, competitive landscape, regulatory requirements, the Company’s ability to successfully implement its growth strategies and effectively manage costs and operations, and unforeseen business challenges. The Company encourages investors to review other factors that may affect its future results in the Company’s registration statement, periodic reports, including its Annual Report on Form 20-F and Current Report on Form 6-K, and in its other filings with the SEC.

Contact Information
The Blueshirt Group
Jack Wang
Email: Jack@blueshirtgroup.co

AUTOZI INTERNET TECHNOLOGY (GLOBAL) LTD.

COMBINED AND CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE

INCOME/(LOSS) (In U.S. dollars in thousands, except for share and per share data, or otherwise noted)

For the years ended September 30,

2023

2024

Revenues

113,541

124,737

Cost of revenues

(113,045)

(123,484)

Gross profit

496

1,253

Operating expenses

Selling and marketing expenses

(1,137)

(1,267)

General and administrative expenses

(5,370)

(4,335)

Research and development expenses

(1,314)

(1,098)

Total operating expenses

(7,821)

(6,700)

Operating loss

(7,325)

(5,447)

Other income/(expense)

Litigation related expenses

(1,456)

(2,969)

Interest expenses, net

(2,060)

(2,707)

Other income, net

214

17

Investment income

78

Total other expenses, net

(3,224)

(5,659)

Loss before income tax expenses

(10,549)

(11,106)

Income tax expenses

Net loss

(10,549)

(11,106)

AUTOZI INTERNET TECHNOLOGY (GLOBAL) LTD.

CONSOLIDATED BALANCE SHEETS

(In U.S. dollars in thousands, except for share and per share data, or otherwise

noted)

As of September 30,

2023

2024

ASSETS

Current assets

Cash and cash equivalents

2,120

$

1,972

Restricted cash

501

Accounts receivable, net

132

417

Advance to suppliers, net

11,553

6,513

Inventories

889

3,270

Prepayments, receivables and other assets, net

1,803

8,120

Deferred offering cost

1,555

Amounts due from related parties, net

403

294

Total current assets

18,455

21,087

Non-current assets

Property, equipment and software, net

441

427

Operating lease right-of-use assets

139

343

Total non-current assets

580

770

TOTAL ASSETS

19,035

$

21,857

LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY

Current liabilities

Short-term borrowings

5,739

8,131

Convertible bonds

4,180

4,346

Accounts payable

1,389

2,868

Deferred revenues

8,913

6,545

Accrued expenses and other current liabilities

11,485

17,189

Payable to redeemable non-controlling interests

14,893

16,616

Lease liabilities, current

352

530

Amounts due to related parties

478

767

Total current liabilities

47,429

56,992

Non-current liabilities

Lease liabilities, non-current

17

42

Total non-current assets

17

42

TOTAL LIABILITIES

47,446

57,034

Mezzanine equity

Redeemable principal interests (US$0.000001 par value; 28,900,700 and nil shares issued and
outstanding as of September 30, 2023 and 2024, respectively)*

118,860

Total mezzanine equity

118,860

$

Shareholders’ deficit

Ordinary shares (US$0.000001 par value; 500,000,000,000 and 500,000,000,000 shares
authorized as of September 30, 2023 and 2024; 73,580,500 and nil shares issued and outstanding
as of September 30, 2023 and 2024, respectively)*

Class A ordinary shares (US$0.000001 par value; 480,000,000,000 and 480,000,000,000 shares
authorized as of September 30, 2023 and 2024; nil and 70,386,100 shares issued and outstanding
as of September 30, 2023 and 2024, respectively)*

Class B ordinary shares (US$0.000001 par value; 20,000,000,000 and 20,000,000,000 shares
authorized as of September 30, 2023 and 2024; nil and 34,595,100 shares issued and outstanding
as of September 30, 2023 and 2024, respectively)*

Subscription receivable

Additional paid-in capital

4,579

84,824

Accumulated deficit

(166,020)

(129,532)

Accumulated other comprehensive income

14,699

10,967

Total AUTOZI shareholders’ deficit

(146,742)

(33,741)

Non-controlling interests

(529)

(1,436)

Total shareholders’ deficit

(147,271)

(35,177)

TOTAL LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ DEFICIT

19,035

21,857

* The shares and per share information are presented on a retroactive basis to reflect the Company’s historic reorganization and share splits. For more information, please refer to the Notes To Combined And Consolidated Financial Statements in the Company’s annual report on Form 20-F for the fiscal year ended September 30, 2024.

Health In Tech to Attend the 2025 HCAA Executive Forum with Self-Funding Solutions

Leadership Team to Connect with Health Industry Leaders
to Discuss Quoting Efficiency and Customizable Coverage

STUART, Fla., Jan. 28, 2025 /PRNewswire/ — Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, is attending the 2025 Health Care Administrators Association (“HCAA”) Executive Forum to promote an industry-leading quoting power of the company’s proprietary SaaS platform, the Enhanced Do It Yourself Benefits System (eDIYBS).

Hosted at the Bellagio in Las Vegas from February 10-12, 2025, the HCAA 2025 Executive Forum connects leaders, innovators, and entrepreneurs from hundreds of businesses across the healthcare, Insurtech insurance, and software industries.

“Heading into 2025, affordability and flexibility remain paramount for us and our clients,” said Health In Tech CEO Tim Johnson. “HCAA is a great opportunity for us to connect with industry leaders and potential partners to share how eDIYBS can provide those solutions for self-funded health plans.”

About eDIYBS: Streamlining Self-Funding and Customizing Ancillary Coverage

Health In Tech streamlines how brokers, groups, and TPAs approach self-funding with its eDIYBS platform. eDIYBS seeks to improve the quoting process for small and level-funded plans, and to make it more efficient and adaptable, focusing on flexibility in proposal generation efficiency. The SaaS platform allows users to quote 12 plans with four tiers while customizing their plan return options and selecting networks and plan designs, typically in just a few minutes.

A range of ancillary coverage options ManhattanLife provides are also accessible through the quoting platform. Options include Critical Illness and Cancer Voluntary Coverage, Accident Indemnity Plus, Dental, Vision, Term Life, and GAP Coverage. This diverse selection allows clients to tailor their plans according to their specific needs while helping to provide comprehensive coverage at an affordable cost.

Connect with Health In Tech at the HCAA Executive Forum

Health In Tech leaders Glen Hillyer, Chief Growth Officer; Del Lockett, Chief Operating Officer; and Chris Kurtenbach, Senior Vice President of Operations, will attend the HCAA 2025 Executive Forum to discuss further how eDIYBS can simplify self-funding for clients. 

Contact the team here to learn more about how Health In Tech and eDIYBS can enhance your health plan options.

About Health In Tech 

Health In Tech (Nasdaq: “HIT”) is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s future financial performance, and involve known and unknown risks, uncertainties and other factors, including risks and uncertainties related to the adoption and performance of Health In Tech’s proprietary solutions, evolving market demands, and outcomes from industry engagements, that may cause Health In Tech’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity.

Investor Contact

Investor Relations:
ir@healthintech.com

Intelligent Living Application Group Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HONG KONG, Jan. 28, 2025 /PRNewswire/ — Intelligent Living Application Group Inc. (NASDAQ: ILAG) (“Intelligent Living” or the “Company”), a premium lockset manufacturer in Hong Kong, announced today that, on January 23, 2025, the Company received a letter from the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s ordinary shares listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer meets the minimum bid price requirement for continued listing on Nasdaq under Nasdaq Marketplace Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”).

The notification has no immediate effect on the listing of the Company’s ordinary shares. In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), the Company has a period of 180 calendar days from the date of notification, until July 22, 2025 (the “Compliance Period”), to regain compliance with the Minimum Bid Price Requirement. If at any time before the expiration of the Compliance Period the bid price of the Company’s ordinary shares closes at least $1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written confirmation of compliance. If the Company does not regain compliance by the end of the Compliance Period, the Company may be eligible for an additional 180 calendar day period to regain compliance. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting.

The Company intends to continue actively monitoring the bid price for its ordinary shares between now and the expiration of the Compliance Period and will consider all available options to resolve the deficiency and regain compliance with the Minimum Bid Price Requirement.

About Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc. is a premium lockset manufacturer and distributor headquartered in Hong Kong. Intelligent Living manufactures and sells high quality mechanical locksets to customers mainly in the United States and Canada and has continued to diversify and refine its product offerings in the past 40 years to meet its customers’ needs. Intelligent Living obtained the ISO9001 quality assurance certificate and various accredited quality and safety certificates including American National Standards Institute (ANSI) Grade 2 and Grade 3 standards that are developed by the Builders Hardware Manufacturing Association (BHMA) for ANSI. Intelligent Living keeps investing in self-designed automated product lines, new craftsmanship and developing new products including smart locks. For more information, visit the Company’s website at http://www.i-l-a-g.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC, which are available for review at www.sec.gov

Gamehaus Holdings Inc. Celebrates NASDAQ Listing and Shares Vision for Future Growth

SHANGHAI, Jan. 28, 2025 /PRNewswire/ — Gamehaus Holdings Inc. (“Gamehaus” or the “Company”) (Nasdaq: GMHS), a technology-driven mobile game publisher, today announced its official listing on the Nasdaq Capital Market (“NASDAQ”). The Company’s Class A ordinary shares began trading today under the stock symbol “GMHS,” marking a pivotal step in its continued expansion and commitment to shaping the future of the global gaming industry.

Mr. Feng “Brian” Xie, founder and Chairman of Gamehaus shared the following Letter to Employees with the Gamehaus team:

Dear Gamehaus Team,

Today marks an incredible milestone in our journey as we are officially listed on NASDAQ. This moment is a powerful testament to the hard work and dedication of every one of you. It is not just a celebration of what we’ve accomplished so far, but also the beginning of an exciting new chapter filled with limitless possibilities for our future.

When we founded Gamehaus in October 2016, we set out with a bold vision – to build a truly global game publishing company. At the time, we were small, just a spark in a vast industry, but with our passion for gaming and unwavering determination, we steadily overcame challenges and carved out our place in an intensely competitive market. Over the years, we’ve witnessed transformative shifts in the gaming landscape, from the evolution of traditional gaming to the integration of cutting-edge technologies like artificial intelligence and virtual reality. Each transformation has presented us with new challenges, but also extraordinary opportunities. Through it all, we’ve remained dedicated to empowering small- and medium-sized game developers at every stage of their growth. By combining our strong reputation and industry-leading expertise with cutting-edge, data-driven technologies, we offer comprehensive support that spans the entire development and publishing cycle. This commitment not only enables us to deliver exceptional gaming experiences for players worldwide, but also raises the bar for the industry as a whole.

One of the key drivers of our success has been our team, a group bound by our passion for gaming and shared commitment to excellence. This teamwork has allowed us to achieve the impossible and overcome challenges that might have seemed insurmountable. It’s this sense of unity and collaboration that has allowed us to execute on our vision with precision and drive. But as we all know, the gaming industry is fast-moving and highly competitive. To stay ahead, we can’t simply rely on our past successes. This is why, as we look toward 2025, we’re embracing the theme of “Refresh.” “Refresh” is not about abandoning the past – it’s about reinvigorating our team, our culture, and our approach to innovation. It’s about recognizing that the next phase of growth will come from challenging ourselves to think differently, work more efficiently, and stay ahead of the curve.

We must constantly ask ourselves: What unique value does Gamehaus bring to the global gaming industry? How can we keep surprising and delighting our players? Our goal is not just to be part of the gaming industry but to shape its future. Our ambition is to create games that redefine entertainment and bring joy to millions worldwide. With the “Refresh” mindset, I am confident that Gamehaus will continue to rise as a global leader in the gaming industry – delivering exceptional experiences to our players, generating long-term value to our shareholders, and earning the respect of our peers. As we embark on this exciting new chapter, let’s move forward with renewed energy and determination. Together, let’s embrace the “Refresh” mindset and work toward building an even brighter future for Gamehaus.

Thank you for being part of this incredible journey. The best is yet to come!

Feng “Brian” Xie
Founder and Chairman of Gamehaus

About Gamehaus

Gamehaus Holdings Inc. is a technology-driven mobile game publisher dedicated to nurturing partnerships with small- and medium-sized game developers to amplify their success. “You make successful games. We make games successful” is the company’s mantra, encapsulating its commitment to transforming potential into prosperity through data-driven monetization support and optimizing game publishing solutions. For more information, please visit https://ir.gamehaus.com/

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company’s business plan and outlook. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may”, or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact

Gamehaus Holdings Inc.
Investor Relations
Email: IR@Gamehaus.com

The Blueshirt Group
Jack Wang
Email: Gamehaus@TheBlueshirtGroup.co